Investors are shifting from Tesla to Eli Lilly as the latter’s diabetes and weight loss drugs rake in huge profits. Tesla’s market value dropped by $210 billion (27%) in the first five weeks of 2024, while Eli Lilly’s rose by $140 billion (23%). Eli Lilly’s shares surged 5% on strongContinue Reading